Kiromic BioPharma Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
HOUSTON–(BUSINESS WIRE)–$KRBP #KRBP—Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated…
QCI Redefines Advantage Play Intelligence with MCP-Driven Agentic AI